Recursion Pharmaceuticals
RXRX
#5083
Rank
HK$13.81 B
Marketcap
HK$22.16
Share price
3.86%
Change (1 day)
-31.56%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): -HK$7.05

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$7.06. In 2025 the company made an earnings per share (EPS) of -HK$11.61 an increase over its 2024 EPS that were of -HK$13.02.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$7.05-39.32%
2025-HK$11.61-10.84%
2024-HK$13.025.73%
2023-HK$12.3214.6%
2022-HK$10.7517.39%
2021-HK$9.16